Selected research
Market Structure
Global Naloxone Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Naloxone market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Naloxone is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Naloxone include ADAPT Pharma, Amneal Pharmaceuticals, Amphastar Pharmaceuticals, Kaleo, West Ward Pharmaceuticals, Pfizer, Mylan and Sandoz, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Naloxone market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Naloxone and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Naloxone sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Naloxone market size, projected growth trends, production technologies, key applications, and end-use industries.
Naloxone Segment by Company
ADAPT Pharma
Amneal Pharmaceuticals
Amphastar Pharmaceuticals
Kaleo
West Ward Pharmaceuticals
Pfizer
Mylan
Sandoz
Naloxone Segment by Type
Spray Forms
Injectable Forms
Naloxone Segment by Application
Hospital Pharmacies
Drug Store
Online
Naloxone Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naloxone market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Naloxone and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naloxone.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Naloxone market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Naloxone manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Naloxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Naloxone in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Spray Forms
- Injectable Forms
Applications
- Hospital Pharmacies
- Drug Store
- Online
Companies covered
- ADAPT Pharma
- Amneal Pharmaceuticals
- Amphastar Pharmaceuticals
- Kaleo
- West Ward Pharmaceuticals
- Pfizer
- Mylan
- Sandoz
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Naloxone Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Naloxone Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Naloxone Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Naloxone Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Naloxone Market Dynamics
- 2.1 Naloxone Industry Trends
- 2.2 Naloxone Industry Drivers
- 2.3 Naloxone Industry Opportunities and Challenges
- 2.4 Naloxone Industry Restraints
3 Naloxone Market by Manufacturers
- 3.1 Global Naloxone Revenue by Manufacturers (2021-2026)
- 3.2 Global Naloxone Sales by Manufacturers (2021-2026)
- 3.3 Global Naloxone Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Naloxone Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Naloxone Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Naloxone Manufacturers, Product Type & Application
- 3.7 Global Naloxone Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Naloxone Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Naloxone Players Market Share by Revenue in 2025
- 3.8.3 2025 Naloxone Tier 1, Tier 2, and Tier 3
4 Naloxone Market by Type
- 4.1 Naloxone Type Introduction
- 4.1.1 Spray Forms
- 4.1.2 Injectable Forms
- 4.2 Global Naloxone Sales by Type
- 4.2.1 Global Naloxone Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Naloxone Sales by Type (2021-2032)
- 4.2.3 Global Naloxone Sales Market Share by Type (2021-2032)
- 4.3 Global Naloxone Revenue by Type
- 4.3.1 Global Naloxone Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Naloxone Revenue by Type (2021-2032)
- 4.3.3 Global Naloxone Revenue Market Share by Type (2021-2032)
5 Naloxone Market by Application
- 5.1 Naloxone Application Introduction
- 5.1.1 Hospital Pharmacies
- 5.1.2 Drug Store
- 5.1.3 Online
- 5.2 Global Naloxone Sales by Application
- 5.2.1 Global Naloxone Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Naloxone Sales by Application (2021-2032)
- 5.2.3 Global Naloxone Sales Market Share by Application (2021-2032)
- 5.3 Global Naloxone Revenue by Application
- 5.3.1 Global Naloxone Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Naloxone Revenue by Application (2021-2032)
- 5.3.3 Global Naloxone Revenue Market Share by Application (2021-2032)
6 Global Naloxone Sales by Region
- 6.1 Global Naloxone Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Naloxone Sales by Region (2021-2032)
- 6.2.1 Global Naloxone Sales by Region (2021-2026)
- 6.2.2 Global Naloxone Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Naloxone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Naloxone Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Naloxone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Naloxone Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Naloxone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Naloxone Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Naloxone Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Naloxone Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Naloxone Revenue by Region
- 7.1 Global Naloxone Revenue by Region
- 7.1.1 Global Naloxone Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Naloxone Revenue by Region (2021-2026)
- 7.1.3 Global Naloxone Revenue by Region (2027-2032)
- 7.1.4 Global Naloxone Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Naloxone Revenue (2021-2032)
- 7.2.2 North America Naloxone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Naloxone Revenue (2021-2032)
- 7.3.2 Europe Naloxone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Naloxone Revenue (2021-2032)
- 7.4.2 Asia-Pacific Naloxone Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Naloxone Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Naloxone Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 ADAPT Pharma
- 8.1.1 ADAPT Pharma Company Information
- 8.1.2 ADAPT Pharma Business Overview
- 8.1.3 ADAPT Pharma Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 ADAPT Pharma Naloxone Product Portfolio
- 8.1.5 ADAPT Pharma Recent Developments
- 8.2 Amneal Pharmaceuticals
- 8.2.1 Amneal Pharmaceuticals Company Information
- 8.2.2 Amneal Pharmaceuticals Business Overview
- 8.2.3 Amneal Pharmaceuticals Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Amneal Pharmaceuticals Naloxone Product Portfolio
- 8.2.5 Amneal Pharmaceuticals Recent Developments
- 8.3 Amphastar Pharmaceuticals
- 8.3.1 Amphastar Pharmaceuticals Company Information
- 8.3.2 Amphastar Pharmaceuticals Business Overview
- 8.3.3 Amphastar Pharmaceuticals Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Amphastar Pharmaceuticals Naloxone Product Portfolio
- 8.3.5 Amphastar Pharmaceuticals Recent Developments
- 8.4 Kaleo
- 8.4.1 Kaleo Company Information
- 8.4.2 Kaleo Business Overview
- 8.4.3 Kaleo Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Kaleo Naloxone Product Portfolio
- 8.4.5 Kaleo Recent Developments
- 8.5 West Ward Pharmaceuticals
- 8.5.1 West Ward Pharmaceuticals Company Information
- 8.5.2 West Ward Pharmaceuticals Business Overview
- 8.5.3 West Ward Pharmaceuticals Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 West Ward Pharmaceuticals Naloxone Product Portfolio
- 8.5.5 West Ward Pharmaceuticals Recent Developments
- 8.6 Pfizer
- 8.6.1 Pfizer Company Information
- 8.6.2 Pfizer Business Overview
- 8.6.3 Pfizer Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Pfizer Naloxone Product Portfolio
- 8.6.5 Pfizer Recent Developments
- 8.7 Mylan
- 8.7.1 Mylan Company Information
- 8.7.2 Mylan Business Overview
- 8.7.3 Mylan Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Mylan Naloxone Product Portfolio
- 8.7.5 Mylan Recent Developments
- 8.8 Sandoz
- 8.8.1 Sandoz Company Information
- 8.8.2 Sandoz Business Overview
- 8.8.3 Sandoz Naloxone Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sandoz Naloxone Product Portfolio
- 8.8.5 Sandoz Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Naloxone Value Chain Analysis
- 9.1.1 Naloxone Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Naloxone Production Mode & Process
- 9.2 Naloxone Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Naloxone Distributors
- 9.2.3 Naloxone Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst